机译:深度过滤对来自CHO细胞培养物的单克隆抗体下游加工期间二硫键降低的影响
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
Bristol Myers Squibb Co BioProc Dev 1201 Eastlake Ave E Seattle WA 98102 USA;
air overlay; antibody; cell lysis; depth filtration; differential pressure; dissolved oxygen; disulfide reduction;
机译:深度过滤对来自CHO细胞培养物的单克隆抗体下游加工期间二硫键降低的影响
机译:硫氧还蛋白还原变构二硫键对单克隆抗体治疗潜力的影响
机译:谷胱甘肽和肝癌系统有助于重组单克隆抗体在生物加工期间的二硫键减少
机译:上层和下层的整合,用于混合连续过程的开发和CHO细胞培养中稳定的单克隆抗体的生产
机译:单克隆抗体的下游纯化中宿主细胞蛋白质杂质和蛋白质间相互作用。
机译:硫氧还蛋白还原变构二硫键对单克隆抗体治疗潜力的影响
机译:肝素减少对单克隆抗体治疗潜力的影响